Friday, September 10, 2021

A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness



Ivermectin, a US Food and Drug Administration-approved anti-parasitic agent, was found to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in vitro.

ORIGINAL LINK